Charles Explorer logo
🇬🇧

Calretinin immunoreactivity in focal cortical dysplasias and in non-malformed epileptic cortex

Publication at First Faculty of Medicine |
2010

Abstract

Calretinin immunoreactivity was quantitatively evaluated and the density of calretinin + neuronal profiles was quantified. Brain tissue from 24 patients neurosurgically treated for pharmacoresistent epilepsy was examined.

As a control, post-mortem acquired neocortical samples, of nine patients without any brain affecting disease were used. The overall density of CR+ neurons was significantly decreased in focal cortical dysplasia (FCD) type I (to 70 % of control values) and even more in FCD type II (50 % of controls).

In normal temporal neocortex resected together with sclerotic hippocampus no change compared to controls was found. in CR+ neuronal density. Our results may contribute to the better understandiung of the role of individual interneuronal populations in epileptogenesis.